Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia

被引:5
|
作者
Okuturlar, Yildiz [1 ]
Akalin, Nilgul [2 ]
Kaptanogullari, Ozlem Harmankaya [2 ]
Guner, Nurten Turan [3 ]
Yilmaz, Deniz [1 ]
Gedikbasi, Asuman [4 ]
Soyluk, Ozlem [5 ]
Mert, Meral [5 ]
Serin, Sibel Ocak [6 ]
Kocoglu, Hakan [1 ]
Hursitoglu, Mehmet [1 ]
Kumbasar, Abdulbaki [1 ]
机构
[1] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey
[2] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Nephrol, Istanbul, Turkey
[3] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Radiol, Istanbul, Turkey
[4] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Biochem, Istanbul, Turkey
[5] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Endocrinol & Metab, Istanbul, Turkey
[6] Umraniye Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey
关键词
Anemia; arylesterase; atherosclerosis; chronic kidney disease; paraoxonase; INTIMA-MEDIA THICKNESS; CHRONIC-RENAL-FAILURE; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; PON1; STROKE; ASSOCIATION; ADULTS;
D O I
10.3109/0886022X.2016.1162080
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: Altered paraoxonase (PON) and arylesterase (ARE) activities have been shown in anemic chronic kidney disease (CKD) patients and in iron deficiency anemia (IDA) patients. Whether accompanying anemia alone is responsible for this diminished PON and ARE activities in CKD patients or an additive factor for this is not well studied. Therefore, we tried to clarify this issue here. Methods: A total of 82 subjects that consisted of 19 patients with IDA (group 1), 23 anemic CKD patients (group 2), and 40 age and sex matched healthy subjects (group 3) were enrolled. Carotid intima media thickness (CIMT), serum total thiol (-SH), PON, and ARE activities of the participants were analyzed. Results: Group 2 patients had significantly lowest serum levels of Total -SH, PON and ARE. Further comparison showed that total -SH, PON and ARE levels were lower in group 1 than group 3 (p=0.0001 in both). Regarding comparison of group 1 and 2, only serum ARE levels were significantly lower in group 2 (p=0.001). PON activity was not different between group 1 and group 2 whereas ARE activity was lower in group 2 than groups 1 and 3. In addition, correlation analysis showed that CIMT was negatively correlated with PON and ARE. Conclusions: This markedly decreased ARE activity in CKD patients, which could not be explained by the anemia alone, may have a role in the pathogenesis of increased atherosclerosis in such patients. Still further studies are needed to certain this.
引用
收藏
页码:781 / 786
页数:6
相关论文
共 50 条
  • [1] Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia
    Aslan, Mehmet
    Kosecik, Mustafa
    Horoz, Mehmet
    Selek, Sahbettin
    Celik, Hakim
    Erel, Ozcan
    [J]. ATHEROSCLEROSIS, 2007, 191 (02) : 397 - 402
  • [2] Serum paraoxonase and arylesterase activities in iron deficiency anemia during pregnancy
    Camuzcuoglu, Hakan
    Toy, Harun
    Vural, Mehmet
    Camuzcuoglu, Aysun
    Taskin, Abdullah
    Celik, Hakim
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2011, 41 (02) : 185 - 191
  • [3] Paraoxonase and Arylesterase Activities in Children With Iron Deficiency Anemia and Vitamin B12 Deficiency Anemia
    Koc, Ahmet
    Cengiz, Murad
    Ozdemir, Zeynep Canan
    Celik, Hakim
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2012, 29 (04) : 345 - 353
  • [4] Serum paraoxonase 1 activity in patients with iron deficiency anemia
    Okuturlar, Yildiz
    Gedikbasi, Asuman
    Akalin, Nilgul
    Gunaldi, Meral
    Yilmaz, Deniz
    Mert, Meral
    Harmankaya, Ozlem
    Soylu, Aliye
    Karakaya, Pinar
    Kumbasar, Abdulbaki
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (04) : 697 - 703
  • [5] Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease
    Coyne, Daniel W.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (15) : 2563 - 2568
  • [6] Iron deficiency: An important determinant of anemia in chronic kidney disease patients
    Canziani, MEF
    Tomyiama, C
    Draibe, SA
    Abensur, H
    Romao, JE
    Pecoits, R
    Riela, MC
    Carmo, WB
    Bastos, MG
    Bregman, R
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V276 - V277
  • [7] Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia
    Przybyszewska, Justyna
    Zekanowska, Ewa
    Kedziora-Kornatowska, Kornelia
    Boinska, Joanna
    Cichon, Roman
    Porzych, Katarzyna
    [J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2013, 123 (03): : 105 - 111
  • [8] Serum paraoxonase and arylesterase activities in patients with chronic otitis media
    Turan, Mahfuz
    Ucler, Rifki
    Aslan, Mehmet
    Kalkan, Ferhat
    Taskin, Abdullah
    Garca, Mehmet Fatih
    Cankaya, Hakan
    [J]. REDOX REPORT, 2015, 20 (06) : 241 - 245
  • [9] Iron Deficiency Anemia in Chronic Kidney Disease
    Gaiter-Gvili, Anat
    Schechter, Amir
    Rozen-Zvi, Benaya
    [J]. ACTA HAEMATOLOGICA, 2019, 142 (01) : 44 - 50
  • [10] Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis
    Aslan, M.
    Horoz, M.
    Nazligul, Y.
    Bolukbas, C.
    Bolukbas, F. F.
    Selek, S.
    Aksoy, N.
    Erel, O.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (07) : 1050 - 1055